FindTrial
Sign In

Supplementation of vitamin D3 for protection of renal function on overweight or obese population with vitamin D deficiency

Supplementation of vitamin D3 for protection of renal function on overweight or obese population with vitamin D deficiency

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018826
Enrollment
Unknown
Registered
2018-10-12
Start date
2018-10-15
Completion date
Unknown
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

Case series:vitamin D drops 400IU/d

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years old; 2. BMI between 26 and 32 kg/m2; 3. Serum 25OHD level below 75 nmol/L.

Exclusion criteria

Exclusion criteria: 1. patients with diabetes, bone metabolic diseases, severe heart, lung, liver and kidney diseases, hematological diseases or tumor; 2. administration for more than 3 months of glucocorticoid or other drugs which may interfere with bone metabolism; 3. gestational or lactate women.

Design outcomes

Primary

MeasureTime frame
25 hydroxyvitamin D;creatinine;usea nitrogen;cystatin C;calcium;phosphorus;—

Countries

China

Contacts

Public ContactZhu Mei

Tianjin Medical University General Hospital

meichuqin@163.com+86 15802238239

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026